SurvivorNet on MSN
A breakthrough for muscle-invasive bladder cancer: Padcev plus Keytruda drug combo could transform treatment around surgery
Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC)—and after decades with few major advances, newly presented data may signal a turning point in how the disease is treated.
Read before the American Association of Genito-Urinary Surgeons at Stockbridge, Mass., in May, 1914. Select the format you want to export the citation of this publication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results